D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Comcast
CMCSA
|
$346M |
| 2 |
Wells Fargo
WFC
|
$285M |
| 3 |
IBM
IBM
|
$264M |
| 4 |
Qualcomm
QCOM
|
$252M |
| 5 |
Mondelez International
MDLZ
|
$214M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$377M |
| 2 |
PayPal
PYPL
|
$310M |
| 3 |
NVIDIA
NVDA
|
$267M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$266M |
| 5 |
AABA
Altaba Inc. Common Stock
AABA
|
$264M |
Sector Composition
| 1 | Technology | 17.21% |
| 2 | Healthcare | 12.97% |
| 3 | Consumer Discretionary | 12.74% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Travel + Leisure Co
TNL
$4.08B
| $70.8M | 0.11% |
1,488,659
+620,846
| +72% | +$29.5M |
|
177
CME Group
CME
$94.4B
| $70.6M | 0.11% |
520,264
-86,891
| -14% | -$11.8M |
|
178
Hubbell
HUBB
$23.2B
| $70.4M | 0.11% |
607,102
+27,219
| +5% | +$3.16M |
|
179
McKesson
MCK
$85.5B
| $70.4M | 0.11% |
458,357
-190,558
| -29% | -$29.3M |
|
180
Nasdaq
NDAQ
$53.6B
| $70.2M | 0.11% |
2,714,949
-312,417
| -10% | -$8.08M |
|
181
Automatic Data Processing
ADP
$120B
| $70.1M | 0.11% |
641,651
+639,196
| +26,036% | +$69.9M |
|
|
LVLT
182
DELISTED
Level 3 Communications Inc
LVLT
| $69.7M | 0.11% |
1,307,910
+392,908
| +43% | +$20.9M |
|
|
MSCC
183
DELISTED
Microsemi Corp
MSCC
| $69.4M | 0.11% |
1,349,034
+550,609
| +69% | +$28.3M |
|
184
Charles River Laboratories
CRL
$8.07B
| $69.3M | 0.11% |
641,674
+107,447
| +20% | +$11.6M |
|
185
Healthpeak Properties
DOC
$12.8B
| $69.2M | 0.11% |
2,487,082
+1,028,349
| +70% | +$28.6M |
|
186
Cognizant
CTSH
$35.1B
| $69M | 0.11% |
951,344
-578,220
| -38% | -$41.9M |
|
187
Costco
COST
$427B
| $68.2M | 0.1% |
414,990
+33,906
| +9% | +$5.57M |
|
188
US Bancorp
USB
$75.9B
| $68.1M | 0.1% |
1,271,487
+639,438
| +101% | +$34.3M |
|
189
Crown Holdings
CCK
$11B
| $68M | 0.1% |
1,139,466
-262,868
| -19% | -$15.7M |
|
190
Amicus Therapeutics
FOLD
$2.46B
| $67.9M | 0.1% |
4,505,500
+435,205
| +11% | +$6.56M |
|
|
VSM
191
DELISTED
Versum Materials, Inc.
VSM
| $66.7M | 0.1% |
1,718,163
-109,655
| -6% | -$4.26M |
|
|
MON
192
DELISTED
Monsanto Co
MON
| $65.9M | 0.1% |
549,971
-407,931
| -43% | -$48.9M |
|
193
Baidu
BIDU
$35.1B
| $65.8M | 0.1% |
+265,471
| New | +$65.8M |
|
194
United Therapeutics
UTHR
$18.1B
| $65M | 0.1% |
555,077
+161,936
| +41% | +$19M |
|
195
Nike
NKE
$109B
| $64.8M | 0.1% |
1,249,427
+838,569
| +204% | +$43.5M |
|
196
Insulet
PODD
$24.5B
| $64.6M | 0.1% |
1,173,715
-32,240
| -3% | -$1.78M |
|
197
Fastenal
FAST
$55.1B
| $64.6M | 0.1% |
5,673,312
+527,240
| +10% | +$6.01M |
|
198
Freeport-McMoran
FCX
$66.5B
| $63.6M | 0.1% |
4,526,447
+405,474
| +10% | +$5.69M |
|
199
Celanese
CE
$5.34B
| $63M | 0.1% |
603,818
-220,942
| -27% | -$23M |
|
|
EQC
200
DELISTED
Equity Commonwealth
EQC
| $62.1M | 0.1% |
2,041,746
-52,425
| -3% | -$1.59M |
|